Integra opens Shanghai office

Integra LifeSciences ($IART) has joined other medical device companies in China--including Covidien ($COV) and Johnson & Johnson ($JNJ)--by opening its first Asia business office in Shanghai.

Alan Eng, who has more than 20 years of multinational healthcare company experience, will head the new office as Integra's Greater China general manager. The office will start off with a staff of 5 and look to create a stronger distribution network for the company's customers in China, Hong Kong and Taiwan.

"Having a direct presence in China enhances our local capability, supports our commitment to this important region, and allows us to offer innovative healthcare solutions for a vast patient population," said JoAnne Harla, Integra's VP for Latin America, Asia Pacific and Canada, in a statement. "Initially, we will focus on our neurosurgical business, but our future plans include product introductions in spine and orthobiologics, and an expansion of our existing orthopedics business."

- get the Integra release

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.